Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 2/20 | 0.58 |
| ▸ | CTSB | P07858 | 2/20 | 0.58 |
| ▸ | KISS1R | Q969F8 | 5/20 | 0.57 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.55 |
| ▸ | NMBR | P28336 | 2/20 | 0.52 |
| ▸ | GRPR | P30550 | 2/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | GLP1R | P43220 | 5/20 | 0.50 |
| ▸ | CCKBR | P32239 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | GCGR | P47871 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30873115 | 0.93 | CAPN1 (0.56) | CAPN1CTSBKISS1RC5AR1GLP1R | |
| SCHEMBL31527736 | 0.91 | F2 (0.56) | KISS1RF2 | |
| SCHEMBL30726621 | 0.87 | GLP1R (0.60) | C5AR1NMBRGRPRKEAP1GLP1R | |
| SCHEMBL30495787 | 0.86 | C5AR1 (0.66) | C5AR1KEAP1GLP1RCCKBRGCGR | |
| SCHEMBL29743013 | 0.86 | C5AR1 (0.59) | C5AR1NMBRGRPRKEAP1GLP1R | |
| SCHEMBL31073544 | 0.86 | KISS1R (0.57) | KISS1RC5AR1NMBRGRPRKEAP1 | |
| SCHEMBL29683494 | 0.86 | C5AR1 (0.57) | KISS1RC5AR1NMBRGRPRF2 | |
| SCHEMBL30906336 | 0.85 | GLP1R (0.61) | C5AR1NMBRGRPRGLP1RCCKBR | |
| SCHEMBL30465929 | 0.85 | CAPN1 (0.54) | CAPN1CTSBKISS1RC5AR1GLP1R | |
| SCHEMBL29558373 | 0.85 | CAPN1 (0.61) | CAPN1CTSBKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | CAPN1 1098/4885CTSB 287/4885KISS1R 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.